Tag: Washington DC
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
FDA Urges AI Device Manufacturers to Improve Testing and Performance Transparency
FDA Urges AI Device Manufacturers to Improve Testing and Performance TransparencyThe Food and Drug Administration (FDA) is calling for increased transparency from developers of medical devices that utilize artificial intelligence (AI) technology....
Reform the FDA to Improve Effectiveness and Accountability
Lee Cooper, a biotechnology investor and ethical bio-innovation instructor, has sounded the alarm on the fragmented nature of the U.S. Food and Drug Agency (FDA). In his recent call for reform, Cooper highlights the...
Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance
RFK Jr.'s Unconventional Stance on Health Insurance
In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
PhRMA Membership Dues Drop by Nearly $100 Million due to Major Drugmakers Exiting
PhRMA Membership Dues Plummet by $100 Million After Major Drugmakers ExitIn a significant blow to the Pharmaceutical Research and Manufacturers of America (PhRMA), three major pharmaceutical companies, AbbVie, AstraZeneca, and Teva, made the decision...
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
Supreme Court Case: FDA Regulation of Flavored Vapes Under Scrutiny
Supreme Court Case: FDA Regulation of Flavored Vapes Under ScrutinyThe Supreme Court is currently at the center of a pivotal case that could reshape how the Food and Drug Administration (FDA) oversees flavored vaping...
Former FDA Chief Seeks to Undermine RFK Jr.’s Senate Confirmation
Former FDA Chief Expresses Concerns Over RFK Jr.'s Senate ConfirmationIn a recent television appearance, Scott Gottlieb, the former commissioner of the Food and Drug Administration under the Trump administration, has raised red flags with...
Jay Bhattacharya: Trump’s Choice to Lead NIH
President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being chosen for the position, as announced by his transition team...
Reining in AI Use in Medicare Advantage: Biden Administration’s Plan
The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....
Dr. Oz appointed by Trump to head Medicare and Medicaid
President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...
ACA Subsidy Boost and Antitrust Speech Impact: What You Need to Know
Good day, and thank you for allowing me to share some interesting insights with you. I'm still active on the platform previously known as Twitter, which shows that old habits die hard. It seems...